FindTrial
Sign In

SG

PROCEDURE6 trials

Sponsors

University of Alberta, Catholic University of the Sacred Heart, University of Illinois at Urbana-Champaign, Beijing Friendship Hospital, Arcus Biosciences, Inc.

Conditions

Androgen-Resistant Prostatic NeoplasmsBariatric Surgery CandidateBariatric Surgical ProcedureCastration Resistant Prostatic NeoplasmsGastroesophageal Reflux DiseaseMorbid ObesityNAFLDNASH With Fibrosis

Phase 1

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer
CompletedNCT04381832
Arcus Biosciences, Inc.Androgen-Resistant Prostatic Neoplasms, Castration Resistant Prostatic Neoplasms, Prostatic Cancer, Castration-Resistant +1
Start: 2020-07-07End: 2024-08-30Updated: 2025-07-22

Unknown Phase

The Microbiology of Bariatric Surgery
CompletedNCT03181347
University of AlbertaMorbid Obesity
Start: 2017-09-03End: 2020-02-03Updated: 2020-11-18
Bariatric Surgery Versus Non-alcoholic Steato-hepatitis
CompletedNCT03524365
Catholic University of the Sacred HeartNon Alcoholic Steatohepatitis
Start: 2018-12-06End: 2022-07-20Updated: 2023-02-21
Fat Taste Sensory Study
NCT03540693
University of Illinois at Urbana-ChampaignBariatric Surgery Candidate, Bariatric Surgical Procedure
Start: 2018-04-06End: 2023-07-06Target: 105Updated: 2021-04-28
Effectiveness of Bariatric Surgery for NAFLD/NASH
RecruitingNCT04366999
Beijing Friendship HospitalBariatric Surgery Candidate, NAFLD, NASH With Fibrosis
Start: 2020-04-21End: 2026-12-31Target: 320Updated: 2024-05-14
Reflux Disease After Gastric Bypass Versus Sleeve Gastrectomy in Morbid Obese Patients: an Italian Study
NCT04763993
Niguarda HospitalGastroesophageal Reflux Disease, Obesity
Start: 2024-05-01End: 2025-05-01Target: 128Updated: 2023-03-22

Related Papers

NAFLD and NAFLD Related HCC: Emerging Treatments and Clinical Trials.
2025-01-019 citations
Performance of Noninvasive Tests for Metabolic Dysfunction-Associated Steatohepatitis and Liver Fibrosis Resolution after Bariatric Surgery
Clinical Chemistry2024-11-29
Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial.
2023-04-21209 citations
Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis
Gut2022-07-1253 citations
Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
2021-06-249 citations
ARC-6: A phase 1b/2, open-label, randomized platform study to evaluate efficacy and safety of etrumadenant (AB928)-based treatment combinations in patients with metastatic castrate-resistant prostate cancer (mCRPC).
Journal of Clinical Oncology2021-05-2013 citations